Depomed Inc (DEPO.OQ)

DEPO.OQ on NASDAQ Stock Exchange Global Select Market

16.24USD
19 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
$16.24
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
290,551
52-wk High
$16.63
52-wk Low
$9.74

DEPO.OQ

Chart for DEPO.OQ

About

Depomed, Inc. (Depomed) is a specialty pharmaceutical company initially focused on neurology, pain and other diseases of the central nervous system. In January 2011, the United States Food and Drug Administration (FDA) approved Gralise (gabapentin) once-daily tablets for the management of postherpetic neuralgia. The Company is... (more)

Overall

Beta: 1.45
Market Cap (Mil.): $953.94
Shares Outstanding (Mil.): 58.74
Dividend: --
Yield (%): --

Financials

  DEPO.OQ Industry Sector
P/E (TTM): 12.14 37.83 38.47
EPS (TTM): 1.34 -- --
ROI: 21.08 18.99 18.25
ROE: 44.39 19.75 19.13
Search Stocks

Earnings vs. Estimates

Search Stocks